The enzymatic complex of tissue factor (TF) and the blood coagulation facto
r VIIa is generally considered to be the initiator of coagulation. Coagulat
ion that occurs at the site of luminal injury to an artery is, along with p
latelet deposition, the cause of arterial thrombosis, which is the leading
cause of death in Western society. Under pathological conditions the intima
, the neointima and the atherosclerotic plaque contain active TF. Therefore
the initiation of thrombosis is believed to be due to TF present in the wa
ll of the pathologically changed artery. This classical view of thrombosis
has been challenged. In this article we review the evidence for the presenc
e of TF activity in various tissues outside the vessel wall, in extracellul
ar form, in encrypted form, and even in plasma. We found TF expression in a
variety of cells in culture after growth factor or cytokine stimulation. T
his TF was often also present in the extracellular matrix, and in addition
we found latent TF on the outside of unbroken smooth muscle cells. Freeze-t
hawing the cells or detergentlysis could activate this TF. We also found TF
activity in native whole blood and in plasma. Inhibition of this circulati
ng TF prevented formation of thrombi on collagen-coated glass slides in an
ex vivo perfusion system. Furthermore, in a thrombosis model in which rat a
orta was injured, TF was found on the intimal surface of the injured aorta.
TF activity was measured in a flow chamber, and it was shown that all meas
urable activity was extracellular. We conclude that blood-borne TF plays a
major role in thrombosis. Encryption of TF present in circulation could be
a mechanism that prevents thrombosis. Alternatively, circulating TF may be
active but below the threshold required for the initiation of blood coagula
tion.